The rat β-tropomyosin (β-TM) gene encodes
both skeletal muscle β-TM mRNA and nonmuscle TM-1 mRNA
via alternative RNA splicing. This gene contains eleven
exons: exons 1–5, 8, and 9 are common to both mRNAs;
exons 6 and 11 are used in fibroblasts as well as in smooth
muscle, whereas exons 7 and 10 are used in skeletal muscle.
Previously we demonstrated that utilization of the 3′
splice site of exon 7 is blocked in nonmuscle cells. In
this study, we use both in vitro and in vivo methods to
investigate the regulation of the 5′ splice site
of exon 7 in nonmuscle cells. The 5′ splice site
of exon 7 is used efficiently in the absence of flanking
sequences, but its utilization is suppressed almost completely
when the upstream exon 6 and intron 6 are present. The
suppression of the 5′ splice site of exon 7 does
not result from the sequences at the 3′ end of intron
6 that block the use of the 3′ splice site of exon
7. However, mutating two conserved nucleotides GU at the
5′ splice site of exon 6 results in the efficient
use of the 5′ splice site of exon 7. In addition,
a mutation that changes the 5′ splice site of exon
7 to the consensus U1 snRNA binding site strongly stimulates
the splicing of exon 7 to the downstream common exon 8.
Collectively, these studies demonstrate that 5′ splice
site competition is responsible, in part, for the suppression
of exon 7 usage in nonmuscle cells.